Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs77826363
rs77826363 		T 0.700 GeneticVariation GWASCAT Genome-wide association study of seasonal affective disorder. 30217971

2018
dbSNP: rs7828021
rs7828021 		C 0.700 GeneticVariation GWASCAT Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. 29559929

2018
dbSNP: rs9321987
rs9321987
UTRN
A 0.700 GeneticVariation GWASCAT Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. 29559929

2018
dbSNP: rs9364726
rs9364726 		A 0.700 GeneticVariation GWASCAT Genome-wide association study of seasonal affective disorder. 30217971

2018
dbSNP: rs9825823
rs9825823
FHIT
0.700 GeneticVariation GWASCAT An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype. 28049566

2017
dbSNP: rs10233018
rs10233018 		A 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs10485715
rs10485715 		C 0.700 GeneticVariation GWASCAT Genome-wide environment interaction between depressive state and stressful life events. 26845276

2016
dbSNP: rs10809520
rs10809520 		T 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs10884216
rs10884216
LINC02627
T 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs111365677
rs111365677 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs112106319
rs112106319
TNC ; DELEC1
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs112538845
rs112538845 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs11924809
rs11924809
DGKG
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs142484554
rs142484554
SPSB4
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs142641502
rs142641502
CSTF3
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs143405544
rs143405544
ADAMTS6
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs143934587
rs143934587 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs1548076
rs1548076 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs1690818
rs1690818
CNTN5
T 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs17156280
rs17156280
CACNA2D1
C 0.700 GeneticVariation GWASCAT Genome-wide environment interaction between depressive state and stressful life events. 26845276

2016
dbSNP: rs182377406
rs182377406 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs183042538
rs183042538
ZHX3
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs183124483
rs183124483
NLK
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs188843168
rs188843168
ATP5MD
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs189864513
rs189864513
LINC01618
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016